Effect of somatostatin on resistance and on capacitance rabbit isolated arteries

European Journal of Pharmacology

Volumn 388, Issue 3, 2000, Pages 255-261

  Ruiz, Emilio ^a   Del Rio, Marcela ^a   Tejerina, Teresa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aorta; Ca2+; Mesenteric artery; Somatostatin

Indexed keywords

SOMATOSTATIN;

ANIMAL TISSUE; AORTA; ARTERY; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CAPACITANCE BLOOD VESSEL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR RESISTANCE;

ANIMALS; AORTA; CALCIUM; CELL MEMBRANE; HUMANS; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; POTASSIUM CHLORIDE; RABBITS; SOMATOSTATIN; VASCULAR CAPACITANCE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0033952790     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00903-6     Document Type: Article

References (35)

1. 2+ movements Syntocinon. J. Pharm. Pharmacol. 36:1984;521-526.
2. Benham C., Tsien R. Noradrenaline modulation of calcium channels in single smooth muscle cells from rabbit ear artery. J. Physiol. 404:1988;767-784.
3. Boch J., Kravetz D., Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 80:1981;518-525.
4. Bolton T. Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59:1979;606-718.
5. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Gullemin R. Hypothalamic polypeptide that inhibit the secretion of immunoreactive pituitary growth hormone. Science. 179:1973;77-79.
6. 2+ antagonists-induced vasodilatation. Annu. Rev. Pharmacol. Toxicol. 23:1983;296-373.
7. 2+ antagonist on Ca fluxes in resistance vessels. J. Cardiovasc. Pharmacol. Toxicol. 23:1982;373-376.
8. 2+ dependence and diltiazem inhibition of contraction in rabbit conduit arteries and mesenteric resistance vessels. Blood. 21:1984;23-31.
9. 2+ antagonists on isolated rat and rabbit mesenteric resistance vessels. Ann. N. Y. Acad. Sci. 522:1988;838-850.
10. Cauvin C., Tejerina T., Van Breemen C. Effects of atriopeptin III on isolated mesenteric resistance vessels from SHR and WKY. Am. J. Physiol. 253:1987;H1612-H1617.
11. Cronin M.J., Rogol A.D., Myers G.A., Hewlett E.L. Pertussis toxin blocks the somatostatin-induced inhibition of growth hormone release and adenosine 3,5-monophosphate accumulation. Endocrinology. 113:1983;209-215.
12. Day S.M., Gu J., Polak J.M., Bloom S.R. Somatostatin in the human heart and comparison with guinea pig and rat heart. Br. Heart J. 53:1985;153-157.
13. 2+ entry blockade. Pharmacol. Rev. 38:1986;321-416.
14. 2+ entry in vascular smooth muscle. J. Cardiovasc. Pharmacol. 10(Suppl. 8):1987;44-48.
15. 2+ removal upon vascular smooth contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther. 159:1964;91-97.
16. Jaspan J., Polonsky K., Lewis M., Moossa R. Reduction in portal vein flow by somatostatin. Diabetes. 28:1979;888-892.
17. 2+ produced by somatostatin. J. Biol. Chem. 263:1987;215-216.
18. Koch B., Schonbrunn A. Characterization of the cyclic AMP-independent actions of somatostatin in GH cells: II. An increase in potassium conductance initiates somatostatin-induced inhibition of prolactin secretion. J. Biol. Chem. 263:1987;226-234.
19. 2+ store in rabbit aorta. J. Physiol. 357:1984;327-339.
20. Leszczynski D., Zhao Y., Cathapermal S., Nilsson J., Foegh M. Rat heart smooth muscle cells express high and low affinity receptors for somatostatin-14, which are involved in regulation of cell proliferation. Life Sci. 53:1993;1663-1674.
21. Meisheri K., Hwang O., Van Breemen C. Evidence for two separate Ca entry pathways in smooth muscle plasmalemma. J. Membr. Biol. 59:1981;19-25.
22. 2+ inward current in guinea-pig atria. Br. J. Pharmacol. 99:1990;587-591.
23. Pennefather P., Heisler S., Macdonald J. A potassium conduct contributes to the action of somatostin-14 to suppress ACTH secretion. Brain Res. 444:1988;346-350.
24. Quins P., Brioscoe A., Muttall A., Smith H. Species variation in arterial-myocardial sensitivity to verapamil. Cardiovasc. Res. 15:1981;398-402.
25. Samnegard H., Thulin L., Andreen M., Tyden G., Hallberg D., Efendic S. Circulatory effects of somatostatin in anesthetized dog. Acta Chir. Scand. 145:1979;209-212.
26. 2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity. Eur. J. Pharmacol. 203:1991;337-344.
27. Sieber G.C., Mosca P.G., Groszmann R.J. Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats. Am. J. Physiol. 262:1992;G274-G277. (Gastrointest. Liver Physiol. 25).
28. 2+ to activation of contraction in isolated rat portal vein. Acta Physiol. Scand. 95:1975;263-269.
29. Tejerina T., Cauvin C., Tamargo J. Effects of oxodipine on isolated rabbit aorta and mesenteric resistance vessel. Eur. J. Pharmacol. 219:1992;279-284.
30. 2+ movements in the isolated rabbit aorta. Eur. J. Pharmacol. 148:1988;239-246.
31. 2+ channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG-15 cells. Proc. Natl. Acad. Sci. U. S. A. 88:1986;9832-9836.
32. Tyden G., Samnegard H., Thulin l., Muhrbeck O., Efendic S. Circulatory effects of somatostatin in anesthetized man. Acta Chir. Scand. 145(7):1979;443-446.
33. + channels through protein dephosphorylation. Nature. 351:1991;530-573.
34. Yatani A., Codina J., Sekura R., Birmbaumer L., Brown A. Reconstitution of somatostatin and muscarinic receptor-mediated stimulation of K-channels by isolated-GK protein in cloned rat anterior pituitary cell membranes. Mol. Endocrinol. 1:1987;283-289.
35. 2+ channels in rMTC 6-23 cells: possible involvement of a pertussis toxin-sensitive G-protein. Acta Endocrinol. (Copenhagen). 127:1992;378-384.